Maravai LifeSciences Holdings, Inc. (MRVI)

MRVI Revenue

Maravai LifeSciences Holdings had revenue of $51.44M in the quarter ending June 30, 2026, with 8.53% growth. This brings the company's total for the last twelve months to $208.78M, down -5.03% year-over-year. In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%. That makes Maravai LifeSciences Holdings the 17,168th largest company in the world by revenue and 2,859th in the United States.

• Revenue (ttm): $208.78M
• Revenue Growth: -5.03%
• P/S Ratio: 9.43
• Revenue / Employee: $503,072
• Employees: 415
• Market Cap: 1.97B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• TriLink 119.79M 64.5%
• Cygnus 65.96M 35.5%

By Geography

Chart

• North America 112.38M 60.5%
• Asia Pacific 41.47M 22.3%
• Europe, The Middle East and Africa 30.92M 16.6%
• Latin and Central America 971.00K 0.5%

Fiscal year ended Dec 31, 2025 See the full MRVI breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	185.74M	-73.44M	-28.34%
Dec 31, 2024	259.19M	-29.76M	-10.30%
Dec 31, 2023	288.95M	-594.06M	-67.28%
Dec 31, 2022	883.00M	83.76M	10.48%
Dec 31, 2021	799.24M	515.14M	181.33%
Dec 31, 2020	284.10M	140.96M	98.48%
Dec 31, 2019	143.14M	19.31M	15.59%
Dec 31, 2018	123.83M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error